Quantitative measurement of HER2 levels by multiplexed mass spectrometry from FFPE tissue predicts survival in patients treated with anti-HER2 based therapy

被引：0
|
作者：
Nuciforo, Paolo [1 ]
Thyparambil, Sheeno [2 ]
Aura, Claudia [1 ]
Garrido-Castro, Ana [1 ]
Peg, Vicente [1 ]
Jimenez, Jose [1 ]
Hoos, William [2 ]
Burrows, Jon [2 ]
Hembrough, Todd [2 ]
Perez-Garcia, Jose [1 ]
Cortes, Javier [1 ]
Scaltriti, Maurizio [3 ]
机构：
[1] Vall dHebron Inst Oncol, Barcelona, Spain
[2] Oncoplex Diagnost, Rockville, MD USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-11-29
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Anti-HER2 Therapy in Elderly Breast Cancer Patients
    Sawaki, Masataka
    REVIEWS ON RECENT CLINICAL TRIALS, 2014, 9 (04) : 263 - 266
  • [42] Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
    Zhang, Shaohua
    Li, Lei
    Wang, Tao
    Bian, Li
    Hu, Haixu
    Xu, Chunhong
    Liu, Bing
    Liu, Yi
    Cristofanilli, Massimo
    Jiang, Zefei
    BMC CANCER, 2016, 16
  • [43] Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
    Shaohua Zhang
    Lei Li
    Tao Wang
    Li Bian
    Haixu Hu
    Chunhong Xu
    Bing Liu
    Yi Liu
    Massimo Cristofanilli
    Zefei Jiang
    BMC Cancer, 16
  • [44] Gene therapy using plasmid DNA-encoded anti-HER2 antibody for cancers that overexpress HER2
    Kim, H.
    Danishmalik, S. N.
    Hwang, H.
    Sin, J-I
    Oh, J.
    Cho, Y.
    Lee, H.
    Jeong, M.
    Kim, S-H
    Hong, H. J.
    CANCER GENE THERAPY, 2016, 23 (10) : 341 - 347
  • [45] Her2 positive subtype and breast cancer brain metastasis: any effect of anti-Her2 targeted therapy?
    Kadri Altundag
    Journal of Neuro-Oncology, 2017, 135 : 639 - 639
  • [46] Gene therapy using plasmid DNA-encoded anti-HER2 antibody for cancers that overexpress HER2
    H Kim
    S N Danishmalik
    H Hwang
    J-I Sin
    J Oh
    Y Cho
    H Lee
    M Jeong
    S-H Kim
    H J Hong
    Cancer Gene Therapy, 2016, 23 : 341 - 347
  • [47] Her2 positive subtype and breast cancer brain metastasis: any effect of anti-Her2 targeted therapy?
    Altundag, Kadri
    JOURNAL OF NEURO-ONCOLOGY, 2017, 135 (03) : 639 - 639
  • [48] ESAM reduces anti-HER2 therapy sensitivity by activating mTOR pathway in HER2 positive breast cancer
    Wu, Jiong
    Zhou, Xujie
    Chi, Yayun
    Xue, Jingyan
    CANCER RESEARCH, 2023, 83 (05)
  • [49] Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2: HER2 dimerization in a clinic-based cohort of patients with metastatic breast cancer
    Toi, M.
    Sperinde, J.
    Huang, W.
    Saji, S.
    Ohno, S.
    Nakamura, S.
    Iwata, H.
    Masuda, N.
    Aogi, K.
    Bates, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy
    Giuliano, Mario
    Hu, Huizhong
    Wang, Yen-Chao
    Fu, Xiaoyong
    Nardone, Agostina
    Herrera, Sabrina
    Mao, Sufeng
    Contreras, Alejandro
    Gutierrez, Carolina
    Wang, Tao
    Hilsenbeck, Susan G.
    De Angelis, Carmine
    Wang, Nicholas J.
    Heiser, Laura M.
    Gray, Joe W.
    Lopez-Tarruella, Sara
    Pavlick, Anne C.
    Trivedi, Meghana V.
    Chamness, Gary C.
    Chang, Jenny C.
    Osborne, C. Kent
    Rimawi, Mothaffar F.
    Schiff, Rachel
    CLINICAL CANCER RESEARCH, 2015, 21 (17) : 3995 - 4003
12345